Merit Stock Based Compensation from 2010 to 2025

MMSI Stock

USD 110.29 1.81 1.67%

Merit Medical's Stock Based Compensation is increasing with slightly volatile movements from year to year. Stock Based Compensation is estimated to finish at about 25.8 M this year. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

1995-12-31

Previous Quarter

7 M

Current Value

6.7 M

Quarterly Volatility

1.9 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Merit Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merit Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 122.3 M, Interest Expense of 18.7 M or Total Revenue of 1.5 B, as well as many indicators such as Price To Sales Ratio of 2.66, Dividend Yield of 0.0 or PTB Ratio of 3.6. Merit financial statements analysis is a perfect complement when working with Merit Medical Valuation or Volatility modules.

Check out the analysis of Merit Medical Correlation against competitors.

Latest Merit Medical's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Merit Medical Systems over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Merit Medical's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merit Medical's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Merit Stock Based Compensation Regression Statistics

	Arithmetic Mean	9,444,222
	Geometric Mean	4,868,420
	Coefficient Of Variation	96.56
	Mean Deviation	7,928,902
	Median	6,117,000
	Standard Deviation	9,119,549
	Sample Variance	83.2T
	Range	25.6M
	R-Value	0.94
	Mean Square Error	9.7T
	R-Squared	0.89
	Slope	1,807,737
	Total Sum of Squares	1247.5T

Merit Stock Based Compensation History

	2025	25.8 M
	2024	24.5 M
	2023	21.3 M
	2022	18 M
	2021	16.1 M
	2020	14.3 M
	2019	9.4 M

Other Fundumenentals of Merit Medical Systems

Stock Based Compensation To Revenue

Merit Medical Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock	Long Term Debt	Good Will	Property Plant Equipment	Current Deferred Revenue	Short Term Investments	Net Tangible Assets	Long Term Debt Total	Deferred Long Term Liab	Long Term Investments	Accumulated Depreciation	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.74	0.97	0.98	0.98	0.95	0.4	0.86	0.96	0.95	0.9	0.96	0.9	0.58	0.85	0.76	0.47	0.61	0.76	-0.9	-0.01	0.86	0.83	0.82
Total Stockholder Equity	0.98		0.69	0.97	0.99	0.93	0.9	0.54	0.87	0.98	0.98	0.81	0.97	0.92	0.62	0.87	0.77	0.45	0.65	0.79	-0.94	0.02	0.82	0.75	0.83
Net Debt	0.74	0.69		0.65	0.74	0.75	0.55	0.42	0.85	0.69	0.69	0.65	0.82	0.84	0.31	0.56	0.15	0.91	0.66	0.57	-0.68	-0.02	0.5	0.39	0.34
Retained Earnings	0.97	0.97	0.65		0.95	0.94	0.95	0.36	0.76	0.96	0.9	0.88	0.93	0.87	0.46	0.8	0.8	0.37	0.49	0.67	-0.86	0.0	0.82	0.84	0.85
Net Receivables	0.98	0.99	0.74	0.95		0.92	0.88	0.56	0.9	0.97	0.98	0.79	0.98	0.95	0.63	0.87	0.72	0.52	0.68	0.79	-0.95	0.01	0.8	0.71	0.8
Total Liab	0.98	0.93	0.75	0.94	0.92		0.96	0.24	0.82	0.91	0.87	0.96	0.92	0.84	0.51	0.8	0.72	0.47	0.55	0.71	-0.83	-0.03	0.87	0.88	0.77
Total Current Assets	0.95	0.9	0.55	0.95	0.88	0.96		0.14	0.68	0.88	0.83	0.96	0.84	0.74	0.5	0.79	0.86	0.22	0.39	0.64	-0.78	-0.05	0.89	0.96	0.86
Short Term Debt	0.4	0.54	0.42	0.36	0.56	0.24	0.14		0.6	0.51	0.64	-0.01	0.58	0.62	0.52	0.51	0.18	0.46	0.67	0.52	-0.66	0.1	0.2	-0.11	0.31
Intangible Assets	0.86	0.87	0.85	0.76	0.9	0.82	0.68	0.6		0.84	0.91	0.66	0.91	0.88	0.66	0.71	0.41	0.75	0.87	0.88	-0.86	0.19	0.67	0.48	0.52
Accounts Payable	0.96	0.98	0.69	0.96	0.97	0.91	0.88	0.51	0.84		0.95	0.79	0.96	0.92	0.52	0.83	0.74	0.46	0.57	0.75	-0.9	0.0	0.79	0.73	0.82
Common Stock	0.95	0.98	0.69	0.9	0.98	0.87	0.83	0.64	0.91	0.95		0.72	0.96	0.92	0.71	0.89	0.72	0.48	0.73	0.84	-0.96	0.03	0.78	0.65	0.79
Long Term Debt	0.9	0.81	0.65	0.88	0.79	0.96	0.96	-0.01	0.66	0.79	0.72		0.79	0.69	0.37	0.67	0.7	0.34	0.36	0.57	-0.66	-0.04	0.84	0.94	0.72
Good Will	0.96	0.97	0.82	0.93	0.98	0.92	0.84	0.58	0.91	0.96	0.96	0.79		0.96	0.58	0.83	0.64	0.62	0.69	0.77	-0.94	0.01	0.76	0.66	0.75
Property Plant Equipment	0.9	0.92	0.84	0.87	0.95	0.84	0.74	0.62	0.88	0.92	0.92	0.69	0.96		0.47	0.81	0.53	0.66	0.66	0.68	-0.9	-0.09	0.66	0.54	0.66
Current Deferred Revenue	0.58	0.62	0.31	0.46	0.63	0.51	0.5	0.52	0.66	0.52	0.71	0.37	0.58	0.47		0.67	0.56	0.21	0.68	0.75	-0.74	0.21	0.58	0.38	0.53
Short Term Investments	0.85	0.87	0.56	0.8	0.87	0.8	0.79	0.51	0.71	0.83	0.89	0.67	0.83	0.81	0.67		0.78	0.28	0.49	0.63	-0.9	-0.39	0.77	0.67	0.84
Net Tangible Assets	0.76	0.77	0.15	0.8	0.72	0.72	0.86	0.18	0.41	0.74	0.72	0.7	0.64	0.53	0.56	0.78		-0.18	0.18	0.49	-0.71	-0.15	0.77	0.85	0.93
Long Term Debt Total	0.47	0.45	0.91	0.37	0.52	0.47	0.22	0.46	0.75	0.46	0.48	0.34	0.62	0.66	0.21	0.28	-0.18		0.7	0.46	-0.47	0.16	0.17	0.03	0.01
Deferred Long Term Liab	0.61	0.65	0.66	0.49	0.68	0.55	0.39	0.67	0.87	0.57	0.73	0.36	0.69	0.66	0.68	0.49	0.18	0.7		0.84	-0.7	0.34	0.45	0.18	0.3
Long Term Investments	0.76	0.79	0.57	0.67	0.79	0.71	0.64	0.52	0.88	0.75	0.84	0.57	0.77	0.68	0.75	0.63	0.49	0.46	0.84		-0.78	0.32	0.76	0.49	0.56
Accumulated Depreciation	-0.9	-0.94	-0.68	-0.86	-0.95	-0.83	-0.78	-0.66	-0.86	-0.9	-0.96	-0.66	-0.94	-0.9	-0.74	-0.9	-0.71	-0.47	-0.7	-0.78		0.04	-0.75	-0.6	-0.75
Short Long Term Debt	-0.01	0.02	-0.02	0.0	0.01	-0.03	-0.05	0.1	0.19	0.0	0.03	-0.04	0.01	-0.09	0.21	-0.39	-0.15	0.16	0.34	0.32	0.04		-0.06	-0.11	-0.22
Net Invested Capital	0.86	0.82	0.5	0.82	0.8	0.87	0.89	0.2	0.67	0.79	0.78	0.84	0.76	0.66	0.58	0.77	0.77	0.17	0.45	0.76	-0.75	-0.06		0.85	0.83
Net Working Capital	0.83	0.75	0.39	0.84	0.71	0.88	0.96	-0.11	0.48	0.73	0.65	0.94	0.66	0.54	0.38	0.67	0.85	0.03	0.18	0.49	-0.6	-0.11	0.85		0.81
Capital Stock	0.82	0.83	0.34	0.85	0.8	0.77	0.86	0.31	0.52	0.82	0.79	0.72	0.75	0.66	0.53	0.84	0.93	0.01	0.3	0.56	-0.75	-0.22	0.83	0.81

Click cells to compare fundamentals

About Merit Medical Financial Statements

Investors use fundamental indicators, such as Merit Medical's Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Merit Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

	Last Reported	Projected for Next Year
Stock Based Compensation	24.5 M	25.8 M
Stock Based Compensation To Revenue	0.02	0.02

Currently Active Assets on Macroaxis

F	Ford Motor
GM	General Motors
S	SentinelOne
GOOG	Alphabet Inc Class C
WD	Walker Dunlop

When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:

How To Invest In Merit

Details

Is Merit Stock a good investment?

Details

What is Merit Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Merit Medical Correlation against competitors.

You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.091

Earnings Share

2.05

Revenue Per Share

22.847

Quarterly Revenue Growth

0.078

Return On Assets

0.0456

The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Merit Stock Based Compensation from 2010 to 2025

Latest Merit Medical's Stock Based Compensation Growth Pattern

Merit Stock Based Compensation Regression Statistics

Merit Stock Based Compensation History

Other Fundumenentals of Merit Medical Systems

Merit Medical Stock Based Compensation component correlations

About Merit Medical Financial Statements

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY